ISIS Neutron and Muon Source Data Journal

Active-Targeted Dendritic Systems for Cancer Therapy ? A SANS Study to Assess Nanoparticle Size and Distribution in Biorelevant Media

Abstract: New chemotherapeutic drugs are increasingly making use of nanoscale architectures and active targeting approaches to minimise side effects while increasing efficacy. One such approach is the use of dendrimers, highly defined polymeric systems, which allow surface functionality to be tuned, with, for example targeting ligands, such as peptides. However systematic studies on the effect these ligands play on structure and binding are lacking. This work aims to use small angle neutron scattering (SANS) to explore how the number and size of the targeting ligands, and associated dendrimer-peptide linker, affect the size (Rg) and size distribution (PDI) of the peptide-dendrimer conjugated nanoparticles. Both of these effects will be assessed in two different biorelevant media, which simulate the conditions associated with both intravenous and oral dosage routes, to help direct future formulation decisions.

Principal Investigator: Dr Daniel Lester
Experimenter: Mr Zameer Ashrif
Experimenter: Mr William Pointer
Experimenter: Mr Owen Tooley
Experimenter: Mr Rowan Radmall
Local Contact: Dr Najet Mahmoudi

DOI: 10.5286/ISIS.E.RB2420083

ISIS Experiment Number: RB2420083

Publisher: STFC ISIS Neutron and Muon Source

Data format: RAW/Nexus
Select the data format above to find out more about it.

Data Citation

The recommended format for citing this dataset in a research publication is as:
[author], [date], [title], [publisher], [doi]

For Example:
Dr Daniel Lester et al; (2024): Active-Targeted Dendritic Systems for Cancer Therapy ? A SANS Study to Assess Nanoparticle Size and Distribution in Biorelevant Media, STFC ISIS Neutron and Muon Source, https://doi.org/10.5286/ISIS.E.RB2420083

Data is released under the CC-BY-4.0 license.